Patients with soft tissue sarcoma of an extremity treated with preoperative image-guided radiotherapy (IGRT) experience significantly fewer long-term treatment side effects compared with a historical control group treated with preoperative, non-image-guided radiation therapy (RT), according to results of the RTOG 0630 trial published online in the Journal of Clinical Oncology.

Virtual Radiologic (vRad) announced an exclusive partnership agreement with Ver2 Digital Medicine (Ver2), a telemedicine services company based in Dubai. vRad is now the exclusive United States-based provider of remote professional radiology interpretation services for Ver2, which offers an integrated portfolio of digital medicine services, including teleradiology, telepathology, as well as remote patient monitoring and remote medical education.

University of North Carolina (UNC) School of Medicine researchers have shown that brain scans can predict which patients with clinical depression are most likely to benefit from a specific kind of talk therapy.

Ian Weissman, DO, is the first Radiology Leadership Institute (RLI) participant to complete all four levels of the RLI program and earn a Certificate of Leadership Mastery.

The Centers for Medicare & Medicaid Services (CMS) has determined that the evidence is sufficient to add a lung cancer screening, counseling and shared decision making visit, and for appropriate beneficiaries, annual screening for lung cancer with low dose computed tomography (LDCT), as an additional preventive service benefit under the Medicare program only if all of the following criteria are met.

Three American Society for Radiation Oncology (ASTRO) staff members have been promoted to new positions: Emily Wilson has been named executive vice president; Dave Adler promoted to vice president of advocacy; and Anne Hubbard promoted to director of health policy, as announced by ASTRO’s board of directors and effective immediately.

IBA (Ion Beam Applications S.A.), a global high-tech leader in the next generation of proton therapy solutions and radiation therapy dosimetry for the treatment of cancer, is proud to support the Union for International Cancer Control (UICC) by participating in World Cancer Day on February 4, 2015. IBA’s mission to “Protect, Enhance and Save Lives” reflects the understanding that lives are impacted by the efforts of all of IBA’s employees in developing the solutions, education and services for fighting cancer. World Cancer Day offers the perfect platform to take a moment and focus on this cause from a very personal aspect.

A new Mayo Clinic study finds that not all women with lymph node-positive breast cancer treated with chemotherapy before surgery need to have all of their underarm nodes taken out. Ultrasound is a useful tool for judging before breast cancer surgery whether chemotherapy eliminated cancer from the underarm lymph nodes, the researchers found. The findings are published in the Journal of Clinical Oncology.